Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241579 · ClinicalTrials.gov registry record · Phase 1
Analgesic Efficacy of Smoked Cannabis
A Phase 1 study of Pain and Hyperalgesia, sponsored by Center for Medicinal Cannabis Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00241579: Completed Phase 1 study of Pain and Hyperalgesia, sponsored by Center for Medicinal Cannabis Research.
NCT00241579 is a Phase 1 study of Pain and Hyperalgesia that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 15 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241579, a Phase 1 study of Pain and Hyperalgesia, has completed, sponsored by Center for Medicinal Cannabis Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether or not inhaled marijuana displays any pain-relieving properties on experimentally-induced pain.
Conditions Studied
Interventions
- DRUG Smoked Cannabis
Study Locations (1)
California
- UC San Diego Medical Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-02 |
| Est. Completion | 2004-01 |
| Phase | Phase 1 |
What the finished NCT00241579 record still lists
NCT00241579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Smoked Cannabis is the first listed.
NCT00241579 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00241579 about?
NCT00241579 is a clinical study titled "Analgesic Efficacy of Smoked Cannabis". The purpose of this study is to determine whether or not inhaled marijuana displays any pain-relieving properties on experimentally-induced pain.
What is the current status of trial NCT00241579?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2002-02. Estimated completion is 2004-01.
What conditions does trial NCT00241579 study?
This clinical trial studies the following conditions: Pain, Hyperalgesia.
What interventions are being tested in trial NCT00241579?
The interventions under investigation include: Smoked Cannabis (DRUG).
Who is sponsoring clinical trial NCT00241579?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241579 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00241579's enrollment target sits among peer trials
15 352nd of 374 higher than 21 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia